As we reached the end of June last week, we review moves from smid-cap biopharma companies during the month of June. See Table 1 for...

$XBI $65.68 | +3.56% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #BNTX +2.4% & $PFE Pfizer and...

$XBI $65.68 | +3.56% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #BNTX +2.4% & $PFE Pfizer and...

As we begin June, we review moves from smid-cap biopharma companies during this past week as well as in May. See Table 1 for weekly...

$XBI $68.77 | +1.84% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #MRNA -2.3% Moderna and the...

$XBI $68.77 | +1.84% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #MRNA -2.3% Moderna and the...

Summary Over 40 Smid-Cap companies currently have active trials involving COVID therapeutics (this includes small molecules and...